At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
GSK GlaxoSmithKline PLC
Market Closed 03-13 16:00:00 EDT
53.39
-0.89
-1.64%
盘后53.33
-0.06-0.12%
19:40 EDT
High54.73Low53.37Vol4.66M
Open54.48D1 Closing54.28Amplitude2.51%
Mkt Cap108.61BTradable Cap103.94BTotal Shares2.03B
T/O251.06MT/O Rate0.24%Tradable Shares1.95B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

FDA Broadens Authorization for GSK's RSV Vaccine to Include Younger Adults
Deep News  ·  03-13 19:50
FDA Broadens Authorization for GSK's RSV Vaccine to Include Younger Adults
GSK Wins Expanded U.S. Approval for Arexvy RSV Vaccine in High-Risk Adults Under 50
TIPRANKS  ·  03-13 18:37
GSK Wins Expanded U.S. Approval for Arexvy RSV Vaccine in High-Risk Adults Under 50
Barclays Sticks to Its Sell Rating for GlaxoSmithKline (GSK)
TIPRANKS  ·  03-12
Barclays Sticks to Its Sell Rating for GlaxoSmithKline (GSK)
GSK Pharma India Publishes Postal Ballot Notice Advertisements in Line With LODR Norms
TIPRANKS  ·  03-12
GSK Pharma India Publishes Postal Ballot Notice Advertisements in Line With LODR Norms
GSK's Wellcovorin Tablets Approved by FDA for Expanded Use
MT Newswires Live  ·  03-10
GSK's Wellcovorin Tablets Approved by FDA for Expanded Use
GSK Adds Elizabeth McKee Anderson to Corporate Responsibility Committee
TIPRANKS  ·  03-09
GSK Adds Elizabeth McKee Anderson to Corporate Responsibility Committee
GSK Adds 690,000 Shares to Treasury in Ongoing Buyback Programme
TIPRANKS  ·  03-09
GSK Adds 690,000 Shares to Treasury in Ongoing Buyback Programme
These 8 drugs could help fight dementia - and they're already on the market
Dow Jones  ·  03-07
These 8 drugs could help fight dementia - and they're already on the market
GSK Pharma India Seeks Shareholder Nod for CFO Appointment via E-Voting Postal Ballot
TIPRANKS  ·  03-07
GSK Pharma India Seeks Shareholder Nod for CFO Appointment via E-Voting Postal Ballot
GSK Files 2025 Annual Report and Sets Timeline for AGM Materials
TIPRANKS  ·  03-05
GSK Files 2025 Annual Report and Sets Timeline for AGM Materials
GSK boosts treasury stock as buyback lifts treasury-held voting rights to 6.04%
TIPRANKS  ·  03-05
GSK boosts treasury stock as buyback lifts treasury-held voting rights to 6.04%
Press Release: SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update
Dow Jones  ·  03-05
Press Release: SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update
Citi Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)
TIPRANKS  ·  03-05
Citi Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)
GSK Discloses ADS Purchase by Chief People Officer Under Pension Plan
TIPRANKS  ·  03-04
GSK Discloses ADS Purchase by Chief People Officer Under Pension Plan
GSK completes acquisition of Rapt Therapeutics
TIPRANKS  ·  03-03
GSK completes acquisition of Rapt Therapeutics
GSK Buys RAPT Therapeutics to Bolster Long-Acting Food Allergy Pipeline
TIPRANKS  ·  03-03
GSK Buys RAPT Therapeutics to Bolster Long-Acting Food Allergy Pipeline
GSK Continues Buyback With £10.9m Treasury Share Purchase
TIPRANKS  ·  03-03
GSK Continues Buyback With £10.9m Treasury Share Purchase
GSK price target raised to 1,700 GBp from 1,600 GBp at Morgan Stanley
TIPRANKS  ·  03-03
GSK price target raised to 1,700 GBp from 1,600 GBp at Morgan Stanley
GSK’s RTS,S Malaria Vaccine Study Nears the Finish Line With Fresh 2026 Update
TIPRANKS  ·  03-03
GSK’s RTS,S Malaria Vaccine Study Nears the Finish Line With Fresh 2026 Update
J.P. Morgan Sticks to Their Sell Rating for GlaxoSmithKline (GSK)
TIPRANKS  ·  03-02
J.P. Morgan Sticks to Their Sell Rating for GlaxoSmithKline (GSK)

Introduction

Company Name.
GlaxoSmithKline PLC
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.
Issue price:
--